149 related articles for article (PubMed ID: 26209885)
21. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
23. The role of IL-11 in immunity and cancer.
Xu DH; Zhu Z; Wakefield MR; Xiao H; Bai Q; Fang Y
Cancer Lett; 2016 Apr; 373(2):156-63. PubMed ID: 26826523
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-11 receptor expression in primary ovarian carcinomas.
Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
[TBL] [Abstract][Full Text] [Related]
25. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.
Bollrath J; Phesse TJ; von Burstin VA; Putoczki T; Bennecke M; Bateman T; Nebelsiek T; Lundgren-May T; Canli O; Schwitalla S; Matthews V; Schmid RM; Kirchner T; Arkan MC; Ernst M; Greten FR
Cancer Cell; 2009 Feb; 15(2):91-102. PubMed ID: 19185844
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
Sammons J; Ahmed N; Khokher MA; Hassan HT
Stem Cells; 2000; 18(3):214-9. PubMed ID: 10840075
[TBL] [Abstract][Full Text] [Related]
27. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease.
Welte T; Zhang XH
Mediators Inflamm; 2015; 2015():804347. PubMed ID: 26783383
[TBL] [Abstract][Full Text] [Related]
29. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
30. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
[TBL] [Abstract][Full Text] [Related]
32. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
33. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
35. The role of the IL-22/IL-22R1 axis in cancer.
Lim C; Savan R
Cytokine Growth Factor Rev; 2014 Jun; 25(3):257-71. PubMed ID: 24856143
[TBL] [Abstract][Full Text] [Related]
36. The CD200-tolerance signaling molecule associated with pregnancy success is present in patients with early-stage breast cancer but does not favor nodal metastasis.
Clark DA; Dhesy-Thind S; Ellis P; Ramsay J
Am J Reprod Immunol; 2014 Nov; 72(5):435-9. PubMed ID: 25041579
[TBL] [Abstract][Full Text] [Related]
37. IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment.
Manore SG; Doheny DL; Wong GL; Lo HW
Front Oncol; 2022; 12():866014. PubMed ID: 35371975
[TBL] [Abstract][Full Text] [Related]
38. STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential.
To SQ; Dmello RS; Richards AK; Ernst M; Chand AL
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053592
[TBL] [Abstract][Full Text] [Related]
39. Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
Jarnicki A; Putoczki T; Ernst M
Cell Div; 2010 May; 5():14. PubMed ID: 20478049
[TBL] [Abstract][Full Text] [Related]
40. A panoramic review and in silico analysis of IL-11 structure and function.
Negahdaripour M; Nezafat N; Ghasemi Y
Cytokine Growth Factor Rev; 2016 Dec; 32():41-61. PubMed ID: 27312790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
